AgentXray — Amazon Seller Central & Ads

ClaudeCommunityby AgentXray

AgentXray connects your Amazon Seller Central and Amazon Ads accounts to Claude. Ask in plain language — "what did I actually make last month?", "which keywords waste spend?", "why is this listing suppressed?" — and the answers come from your own data, not estimates. What you can read (49 read-only tools): - Profit by SKU and for the whole account, from your own settlement reports — the fees Amazon actually charged, not a calculator; payout balance - Ads: campaigns, targets, search terms with verdicts, placements, negatives, Amazon's bid recommendations, TACoS across Sponsored Products, Brands and Display, weekly recommendations priced against your break-even — split by marketplace - Listing doctor: every issue Amazon reports, ranked by sales at risk, with a fix plan checked against Amazon's product-type schema; an image review that shows Claude every image slot - Brand: Brand Analytics keyword gaps, search-term history, competitors, A+ status, Search Query Performance - Inventory: stock history, age, inbound, reorder plan; returns, account health - Traffic and conversion, BSR history, Buy Box status - Every answer states its basis and what is missing, never an estimate Plus 6 memory tools for your goals, rules and follow-ups. What it can propose (18 draft tools, only if you grant write access): bids, budgets, negatives, campaign/target/ad state, placements, prices, listing text and attributes, images, new campaigns and listings, review requests, batched listing fixes. Listing drafts are pre-checked with Amazon, quote where each value came from and link straight to your approval screen. Nothing reaches Amazon until you approve it in the AgentXray app; the token Claude holds cannot approve anything. After a fix is applied, AgentXray checks whether Amazon cleared the issue; 14 days on, it judges each change by net contribution, and you can revert it. Requires an AgentXray account with Amazon Seller Central connected (Amazon Ads optional). 14-day trial.